Index NDX, S&P 500
P/E 50.49
EPS (ttm) 10.32
Insider Own 0.99%
Shs Outstand 83.03M
Perf Week 7.74%
Market Cap 43.04B
Forward P/E 41.31
EPS next Y 12.62
Insider Trans -8.07%
Shs Float 81.77M
Perf Month 6.07%
Income 866.57M
PEG 4.21
EPS next Q 2.89
Inst Own 90.78%
Short Float 2.06%
Perf Quarter -6.22%
Sales 3.72B
P/S 11.55
EPS this Y 10.03%
Inst Trans -0.23%
Short Ratio 3.94
Perf Half Y 21.55%
Book/sh 18.93
P/B 27.53
EPS next Y 13.98%
ROA 28.13%
Short Interest 1.69M
Perf Year 6.90%
Cash/sh 4.81
P/C 108.29
EPS next 5Y 12.00%
ROE 71.91%
52W Range 372.50 - 583.39
Perf YTD -6.11%
Dividend Est. -
P/FCF 54.01
EPS past 5Y 18.76%
ROI 37.78%
52W High -10.68%
Beta 1.34
Dividend TTM -
Quick Ratio 1.10
Sales past 5Y 10.69%
Gross Margin 60.08%
52W Low 39.90%
ATR (14) 13.49
Dividend Ex-Date -
Current Ratio 1.51
EPS Y/Y TTM 24.13%
Oper. Margin 29.90%
RSI (14) 60.27
Volatility 2.73% 2.58%
Employees 11000
Debt/Eq 0.68
Sales Y/Y TTM 8.57%
Profit Margin 23.26%
Recom 2.29
Target Price 581.34
Option/Short Yes / Yes
LT Debt/Eq 0.46
EPS Q/Q 10.06%
Payout 0.00%
Rel Volume 1.48
Prev Close 503.02
Sales Surprise -0.03%
EPS Surprise 3.60%
Sales Q/Q 7.10%
Earnings May 01 BMO
Avg Volume 428.90K
Price 521.11
SMA20 6.76%
SMA50 1.32%
SMA200 4.04%
Trades
Volume 635,053
Change 3.60%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-30-24 Downgrade
Piper Sandler
Overweight → Neutral
$525
Dec-07-23 Initiated
Exane BNP Paribas
Outperform
$602
Dec-04-23 Upgrade
Cleveland Research
Neutral → Buy
Aug-02-23 Downgrade
Atlantic Equities
Overweight → Neutral
$610
Jul-25-22 Downgrade
Stifel
Buy → Hold
$415
Jul-21-22 Upgrade
Goldman
Neutral → Buy
$530 → $435
Jul-12-22 Initiated
Piper Sandler
Overweight
$440
May-05-22 Downgrade
BofA Securities
Buy → Neutral
$550 → $470
Feb-08-22 Initiated
Atlantic Equities
Overweight
$650
Nov-18-21 Initiated
Morgan Stanley
Overweight
Aug-05-21 Resumed
Credit Suisse
Outperform
$735
Jul-12-21 Downgrade
Guggenheim
Buy → Neutral
Feb-17-21 Initiated
Barclays
Overweight
$600
Sep-09-19 Initiated
Goldman
Neutral
$277
May-23-19 Initiated
Guggenheim
Buy
$276
Nov-02-18 Reiterated
BofA/Merrill
Buy
$275 → $235
May-07-18 Reiterated
Stifel
Buy
$215 → $225
Jan-16-18 Initiated
Piper Jaffray
Overweight
$200
Aug-23-17 Upgrade
BofA/Merrill
Neutral → Buy
Jul-28-17 Upgrade
CL King
Neutral → Buy
Show Previous Ratings
Today 02:00PM
08:27AM
May-13-24 02:25PM
May-04-24 07:38AM
May-02-24 02:22PM
02:17PM
Loading…
02:17PM
10:31AM
10:30AM
10:20AM
09:46AM
09:23AM
03:08AM
May-01-24 11:28PM
(Thomson Reuters StreetEvents) -5.02%
02:31PM
10:41AM
09:30AM
Loading…
09:30AM
08:11AM
07:52AM
07:40AM
07:10AM
06:38AM
(Associated Press Finance)
06:30AM
Apr-30-24 10:02AM
Apr-28-24 06:32PM
Apr-26-24 09:15AM
Apr-24-24 12:01PM
Apr-19-24 07:56AM
Apr-12-24 01:53PM
Apr-09-24 06:00PM
12:00PM
12:10PM
Loading…
Apr-05-24 12:10PM
Apr-04-24 04:30PM
Apr-02-24 08:31AM
Mar-29-24 02:15AM
Mar-21-24 05:42AM
Mar-08-24 03:01AM
Mar-06-24 11:30AM
Mar-05-24 03:05AM
Feb-22-24 03:46AM
Feb-20-24 02:00PM
Feb-18-24 01:26PM
Feb-16-24 12:56PM
Feb-15-24 11:53AM
07:00AM
Feb-10-24 02:07AM
Feb-09-24 03:35PM
Feb-08-24 10:34AM
Feb-06-24 02:25PM
(Investor's Business Daily)
08:46AM
02:05AM
(Thomson Reuters StreetEvents)
Feb-05-24 10:31PM
(Morningstar Research) +8.53%
10:37AM
09:30AM
07:45AM
07:40AM
06:53AM
06:39AM
(Associated Press Finance)
06:30AM
Feb-02-24 08:46AM
Jan-31-24 09:15AM
07:29AM
Jan-30-24 12:10PM
Jan-29-24 11:58AM
Jan-25-24 07:18AM
Jan-23-24 03:30PM
Jan-19-24 07:14AM
Jan-15-24 11:33AM
Jan-12-24 07:05AM
07:00AM
Jan-11-24 09:48PM
Dec-18-23 07:40AM
05:19AM
Dec-09-23 01:05AM
Dec-07-23 09:16PM
04:15PM
Dec-06-23 03:25PM
(Investor's Business Daily)
Dec-04-23 08:12PM
(Morningstar Research) +7.05%
Dec-01-23 11:31AM
Nov-16-23 09:28AM
Nov-13-23 06:10AM
Nov-11-23 12:00PM
Nov-09-23 07:48AM
Nov-08-23 07:00AM
Nov-02-23 06:55PM
08:52AM
01:10AM
12:45AM
(Thomson Reuters StreetEvents)
Nov-01-23 10:00PM
02:52PM
09:53AM
09:28AM
08:46AM
06:40AM
(Associated Press Finance)
06:30AM
Oct-31-23 11:25AM
Oct-25-23 10:02AM
Oct-23-23 06:19AM
Oct-13-23 11:40AM
Oct-06-23 07:30AM
Oct-05-23 04:00PM
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kingsley Lawrence D Director May 06 '24 Option Exercise 0.00 339 0 8,883 May 08 07:02 PM SZOSTAK M ANNE Director May 06 '24 Option Exercise 0.00 257 0 257 May 08 07:02 PM Vandebroek Sophie V. Director May 06 '24 Option Exercise 0.00 257 0 1,473 May 08 07:02 PM COLLINS Asha Director May 06 '24 Option Exercise 0.00 257 0 779 May 08 07:01 PM ESSIG STUART Director May 06 '24 Option Exercise 0.00 257 0 1,974 May 08 07:01 PM AYERS JONATHAN W Director May 06 '24 Option Exercise 0.00 257 0 265,651 May 08 07:00 PM Britt Irene Chang Director May 06 '24 Option Exercise 0.00 208 0 208 May 08 07:00 PM POLEWACZYK JAMES F Executive Vice President Mar 06 '24 Option Exercise 422.45 8,104 3,423,547 18,815 Mar 07 05:00 PM POLEWACZYK JAMES F Executive Vice President Mar 06 '24 Sale 558.44 8,104 4,525,596 10,711 Mar 07 05:00 PM Vandebroek Sophie V. Director Mar 05 '24 Option Exercise 245.79 1,404 345,089 2,620 Mar 07 05:00 PM Vandebroek Sophie V. Director Mar 05 '24 Sale 562.98 1,404 790,427 1,216 Mar 07 05:00 PM MAZELSKY JONATHAN JAY President and CEO Feb 21 '24 Option Exercise 206.94 483 99,952 82,047 Feb 22 05:02 PM Underberg Sharon E. EVP, GC & Corporate Secretary Feb 16 '24 Option Exercise 206.94 483 99,952 5,595 Feb 20 05:01 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 15 '24 Option Exercise 206.94 483 99,952 30,835 Feb 20 05:00 PM Smith Martin Alexander Executive Vice President Feb 14 '24 Option Exercise 0.00 337 0 583 Feb 16 05:58 PM Schreck Michael Executive Vice President Feb 14 '24 Option Exercise 0.00 368 0 903 Feb 16 05:58 PM Johnson Michael Perkins EVP and CHRO Feb 14 '24 Option Exercise 0.00 176 0 243 Feb 16 05:56 PM Lane Michael Executive Vice President Feb 14 '24 Option Exercise 0.00 939 0 6,726 Feb 16 05:56 PM MAZELSKY JONATHAN JAY President and CEO Feb 14 '24 Option Exercise 0.00 4,156 0 83,403 Feb 16 05:56 PM Erickson Michael G Executive Vice President Feb 14 '24 Option Exercise 0.00 462 0 10,801 Feb 16 05:54 PM FENNELL GEORGE SVP, Chief Revenue Officer Feb 14 '24 Option Exercise 0.00 370 0 7,082 Feb 16 05:55 PM Hunt Nimrata Executive Vice President Feb 14 '24 Option Exercise 0.00 664 0 11,731 Feb 16 05:55 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 14 '24 Option Exercise 0.00 1,731 0 31,449 Feb 16 05:57 PM POLEWACZYK JAMES F Executive Vice President Feb 14 '24 Option Exercise 0.00 927 0 10,990 Feb 16 05:57 PM FENNELL GEORGE SVP, Chief Revenue Officer Feb 08 '24 Option Exercise 62.00 9,810 608,220 14,910 Feb 09 05:03 PM FENNELL GEORGE SVP, Chief Revenue Officer Feb 08 '24 Sale 573.87 8,198 4,704,559 6,712 Feb 09 05:03 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 07 '24 Option Exercise 141.60 23,326 3,302,962 53,044 Feb 09 05:01 PM MAZELSKY JONATHAN JAY President and CEO Feb 07 '24 Option Exercise 67.85 12,000 814,200 91,247 Feb 09 05:00 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 07 '24 Sale 570.01 23,326 13,295,975 29,718 Feb 09 05:01 PM MAZELSKY JONATHAN JAY President and CEO Feb 07 '24 Sale 572.61 12,000 6,871,319 79,247 Feb 09 05:00 PM POLEWACZYK JAMES F Executive Vice President Dec 07 '23 Option Exercise 253.92 11,636 2,954,645 21,686 Dec 08 05:00 PM POLEWACZYK JAMES F Executive Vice President Dec 07 '23 Sale 521.79 11,636 6,071,500 10,050 Dec 08 05:00 PM MAZELSKY JONATHAN JAY President and CEO Dec 04 '23 Option Exercise 79.54 13,424 1,067,745 86,361 Dec 06 05:01 PM MAZELSKY JONATHAN JAY President and CEO Dec 04 '23 Sale 513.05 7,128 3,657,049 79,233 Dec 06 05:01 PM Lane Michael Executive Vice President Nov 07 '23 Option Exercise 133.76 1,728 231,142 5,774 Nov 08 05:09 PM Smith Martin Alexander Executive Vice President Sep 01 '23 Option Exercise 0.00 19 0 226 Sep 06 05:01 PM MAZELSKY JONATHAN JAY President and CEO Aug 31 '23 Option Exercise 79.54 13,424 1,067,745 86,349 Sep 05 05:01 PM MAZELSKY JONATHAN JAY President and CEO Aug 31 '23 Sale 512.01 13,424 6,873,267 72,925 Sep 05 05:01 PM POLEWACZYK JAMES F Executive Vice President Aug 29 '23 Option Exercise 144.21 16,909 2,438,478 32,947 Aug 31 05:17 PM POLEWACZYK JAMES F Executive Vice President Aug 29 '23 Sale 510.56 22,909 11,696,446 10,038 Aug 31 05:17 PM MAZELSKY JONATHAN JAY President and CEO Aug 05 '23 Option Exercise 0.00 384 0 73,095 Aug 08 05:59 PM MCKEON BRIAN P EVP, CFO and Treasurer Aug 05 '23 Option Exercise 0.00 192 0 29,809 Aug 08 05:59 PM Lane Michael Executive Vice President Aug 03 '23 Option Exercise 187.47 16,027 3,004,598 20,061 Aug 07 05:04 PM Lane Michael Executive Vice President Aug 03 '23 Sale 510.00 16,027 8,173,770 4,034 Aug 07 05:04 PM AYERS JONATHAN W Director May 19 '23 Option Exercise 79.54 10,000 795,400 147,039 May 22 05:00 PM AYERS JONATHAN W Director May 19 '23 Sale 491.35 10,000 4,913,502 137,039 May 22 05:00 PM AYERS JONATHAN W Director May 18 '23 Option Exercise 79.54 10,000 795,400 147,039 May 22 05:00 PM AYERS JONATHAN W Director May 18 '23 Sale 489.23 10,000 4,892,268 137,039 May 22 05:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite